Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity | Patent Number 08222244

US 08222244 B2
Application Number13109511
Publication NumberUS 20110224194 A1
Pendency1 year, 2 months, 2 days
Filled DateMay 17, 2011
Priority DateOct 30, 2001
Publication DateSep 15, 2011
Expiration DateOct 30, 2021
Inventor/ApplicantsPaul William Manley
Paul W Manley
James Douglas Griffin
James D Griffin
ExaminesCOLEMAN, BRENDA LIBBY
Art Unit1624
Technology Center1600
Assignments
Novartis
Current
Novartis
Original
Danafarber Cancer Institute
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.